348
Participants
Start Date
October 11, 2017
Primary Completion Date
May 11, 2026
Study Completion Date
September 11, 2026
enfortumab vedotin (EV)
Intravenous (IV) infusion on days 1 and 8 every 21 days
pembrolizumab
IV infusion on day 1 every 21 days
cisplatin
IV infusion on day 1 every 21 days
carboplatin
IV infusion on day 1 every 21 days
gemcitabine
IV infusion on days 1 and 8 every 21 days
New York University (NYU) Cancer Institute, New York
Weill Cornell Medical College, New York
Memorial Sloan Kettering Cancer Center - Westchester, Harrison
Northwell Cancer Center / Monter Cancer Center, Lake Success
NYU Winthrop Hospital, Mineola
Memorial Sloan Kettering Cancer Center - Nassau, Uniondale
Memorial Sloan Kettering Cancer Center - Commack, Commack
New York Oncology Hematology, P.C., Albany
Site FR33004, Marseille
Roswell Park Cancer Institute, Buffalo
University of Rochester Medical Center, Rochester
Allegheny General Hospital, Pittsburgh
Penn State Milton S. Hershey Medical Center, Hershey
CMOH Broomall, Broomall
Fox Chase Cancer Center, Philadelphia
Georgetown University Medical Center, Washington D.C.
Maryland Oncology Hematology, P.A., Silver Spring
Site FR33005, Dijon
University of Virginia, Charlottesville
Virginia Oncology Associates - Norfolk, Norfolk
UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill
Duke University Medical Center, Durham
Vidant Medical Center, Greenville
Site ES34008, Madrid
Site ES34001, Madrid
Site ES34012, Madrid
Levine Cancer Institute, Charlotte
Medical University of South Carolina/Hollings Cancer Center, Charleston
Carolina Urologic Research Center, Myrtle Beach
Saint Francis Hospital Cancer Center, Greenville
Piedmont Cancer Institute, Atlanta
Winship Cancer Institute / Emory University School of Medicine, Atlanta
Site ES34007, Pamplona
Mayo Clinic Florida, Jacksonville
Site FR33008, Bordeaux
University of Miami, Miami
Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale
Boca Raton Regional Hospital / Lynn Cancer Institute, Boca Raton
Tennessee Oncology / Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute, Chattanooga
Site ES34004, Santander
University of Mississippi Medical Center, Jackson
Toledo Clinic Cancer Center, Toledo
Case Western Reserve University / University Hospitals Case Medical Center, Cleveland
Gabrail Cancer Center Research, LLC, Canton
University of Michigan Comprehensive Cancer Center, Ann Arbor
Henry Ford Health System, Detroit
McLaren Greater Lansing Hospital, Lansing
Medical College of Wisconsin (Milwaukee), Milwaukee
Site FR33010, Moselle
University of Minnesota, Minneapolis
Northwestern Medicine Cancer Center - Kishwaukee / Kishwaukee Cancer Center, DeKalb
Northwestern Medicine Cancer Center Delnor, Geneva
Cardinal Bernardin Cancer Center / Loyola University Medical Center, Maywood
Northwestern Medicine Cancer Center - Warrenville / Central DuPage Hospital - Cancer Care, Warrenville
Decatur Memorial Hospital - Illinois, Decatur
Washington University School of Medicine - Siteman Cancer Center, St Louis
University of Kansas Cancer Center, Westwood
Site FR33001, Strasbourg
Nebraska Hematology Oncology P.C., Lincoln
Site FR33003, Lyon
Site FR33006, Pierre-Bénite
Tulane University Hospital and Clinic, New Orleans
Ochsner Clinic Foundation, New Orleans
Highlands Oncology Group, Fayetteville
Texas Oncology - Tyler, Tyler
Texas Oncology - Fort Worth Cancer Center, Fort Worth
University of Texas Health Science Center at San Antonio, San Antonio
Rocky Mountain Cancer Centers - Aurora, Aurora
Utah Cancer Specialists, Salt Lake City
Mayo Clinic Arizona, Phoenix
Banner MD Anderson Cancer Center, Gilbert
Arizona Oncology Associates, PC - HOPE, Tucson
University of New Mexico Cancer Center, Albuquerque
OptumCare Cancer Center, Las Vegas
Tower Hematology Oncology Medical Group, Beverly Hills
Kaiser Permanente Southern California, Woodland Hills
UC San Diego / Moores Cancer Center, La Jolla
University of California Irvine - Newport, Orange
University of California at San Francisco, San Francisco
Stanford Cancer Center / Blood & Marrow Transplant Program, Stanford
Saint Joseph Heritage Medical Group, Santa Rosa
University of California, Davis Comprehensive Cancer Center, Sacramento
Medical Oncology Associates, Spokane
Alaska Urological Institute, Anchorage
University of Colorado Hospital / University of Colorado, Aurora
Yale Cancer Center, New Haven
Eastern CT Hematology and Oncology Associates, Norwich
University of Chicago Medical Center, Chicago
Southcoast Centers for Cancer Care - Fairhaven Site, Fairhaven
Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge
Hackensack University Medical Center, Hackensack
Memorial Sloan Kettering Cancer Center - Monmouth, Middletown
Memorial Sloan Kettering Cancer Center - Bergen, Montvale
Memorial Sloan Kettering Cancer Center, New York
Site CA11008, East Brampton
Site CA11011, Kingston
Site CA11001, Toronto
Site CA11005, Montreal
Site CA11013, Montreal
Site CA11002, Sherbrooke
Site FR33002, Nice
Site IT39002, Terni
Site PR78701, Rio Piedras
Site ES34006, Barcelona
Site ES34005, Sabadell
Merck Sharp & Dohme LLC
INDUSTRY
Seagen Inc.
INDUSTRY
Astellas Pharma Global Development, Inc.
INDUSTRY